MCL1 and B-cell chronic lymphocytic leukemia: For example, we have demonstrated that MMP-9 binding to α4β1 in CLL cells induces a Lyn/STAT3/Mcl-1 signaling survival pathway, and this function does not require the MMP-9 catalytic activity (78).